BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23247782)

  • 1. [Management of non small cell lung cancer].
    Ourari-Dhahri B; Ben Slima H; Ben Amar J; El Gharbi L; Ali M; Baccar Azzabi S; Aouina H; Bouacha H
    Tunis Med; 2012 Dec; 90(12):847-51. PubMed ID: 23247782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is lung cancer in women different?].
    Ben Aissa A; Mach N
    Rev Med Suisse; 2012 May; 8(342):1108-11. PubMed ID: 22734179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and treatment of patients with non-small cell lung cancer.
    Carr LL; Finigan JH; Kern JA
    Med Clin North Am; 2011 Nov; 95(6):1041-54. PubMed ID: 22032426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of non-resectable stage III non-small cell lung cancer].
    Fournel P
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 2):3S43-7. PubMed ID: 15536352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lung cancer--epidemiology, prognosis and therapy].
    Martini B
    Med Monatsschr Pharm; 2006 Jun; 29(6):217-21. PubMed ID: 16792198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender-related disparities in non-small cell lung cancer.
    Paggi MG; Vona R; Abbruzzese C; Malorni W
    Cancer Lett; 2010 Dec; 298(1):1-8. PubMed ID: 20826048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auditing a new lung cancer service.
    Cullen JP; Glynn C; Murtagh E; Hogan B; Jeffers M; Lane SJ
    Ir Med J; 2004 Oct; 97(9):281-3. PubMed ID: 15568588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent progress and perspectives in the management of patients with lung cancer].
    Barlesi F; Gimenez C; Pibarot M; Kleisbauer JP
    Bull Cancer; 2002 Jan; 89(1):57-66. PubMed ID: 11847027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiology, prognostic factors, staging, and treatment of non-small cell lung cancer].
    André F; Jacot W; Pujol JL; Grunenwald D; Le Chevalier T
    Bull Cancer; 1999 Oct; Suppl 3():17-41. PubMed ID: 10585572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of lung cancer and advances in non-small cell lung cancer.
    Dhabhar BN; Malhotra H; Advani SH
    J Assoc Physicians India; 1992 Jul; 40(7):493. PubMed ID: 1336499
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment based on biological characteristics of lung cancer: biological differences between small cell and non-small cell lung cancer and gene therapy].
    Tanio Y
    Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():337-44. PubMed ID: 9369905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic factors of lung cancer].
    Kleisbauer JP; Thomas P
    Rev Prat; 1993 Apr; 43(7):852-5. PubMed ID: 8394027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of stages I and II non-small-cell lung cancer in a New Zealand study: divergence from international practice and recommendations.
    Stevens W; Stevens G; Kolbe J; Cox B
    Intern Med J; 2008 Oct; 38(10):758-68. PubMed ID: 18298555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodality therapy for non-small-cell lung cancer.
    Lilenbaum RC; Green MR
    Oncology (Williston Park); 1994 May; 8(5):25-31; discussion 32, 35-6. PubMed ID: 8025004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis.
    Dacic S
    Expert Rev Mol Diagn; 2007 Jan; 7(1):77-86. PubMed ID: 17187486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent aspects regarding carcinogenesis in non-small-cell lung cancer.
    Stamatelopoulos A; Baltayiannis N; Roussakis A
    J BUON; 2006; 11(2):127-42. PubMed ID: 17318962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MANAGEMENT OF NON-SMALL CELL LUNG CANCER].
    Sibille A; Paulus A; Martin M; Bourhaba M; Barthélemy N; Radermecker M; Corhay JL; Louis R; Duysinx B
    Rev Med Liege; 2015 Sep; 70(9):432-41. PubMed ID: 26638443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival.
    Steger V; Walles T; Kosan B; Walker T; Kyriss T; Veit S; Dippon J; Friedel G
    Ann Thorac Surg; 2009 Jun; 87(6):1676-83. PubMed ID: 19463576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical management of older people with non-small cell lung cancer in England.
    Beckett P; Callister M; Tata LJ; Harrison R; Peake MD; Stanley R; Woolhouse I; Slade M; Hubbard RB
    Thorax; 2012 Sep; 67(9):836-9. PubMed ID: 22771514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New therapeutic strategies and current research in inoperable locally advanced non small-cell lung cancers (stage IIIB)].
    Le Cesne A; Arriagada R; Grunenwald D; Baldeyrou P; Girard P; Bretel JJ; Le Chevalier T
    Bull Cancer; 1997 Apr; 84(4):413-9. PubMed ID: 9238166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.